Right, because it's easier to serve a market of 30 million from their vantage point than to have a market of 30 million trying to service a market of 300 million in terms of shipment of goods.
I don't know whether those types of decisions have been made by my member companies as a result of the Bioterrorism Act. I can certainly endeavour to find out, and I certainly take your point that this is something that's worth exploring because the economic impacts are probably significant.